Roche Breast Cancer Drug Gets U.S. Pre-Surgery Approval

02.10.2013 - U.S. health regulators expanded the approval of Roche's breast cancer drug Perjeta and will now allow its use to help shrink tumors prior to surgery, the FDA said. The decision...